Martin Smith, PhD
CTO, Pall Corporation

Thank you for taking the time to view our supplement, which has been driven by our desire to share actionable knowledge in a convenient format as well as to act as a guidepost for the evolution of continuous processing. As you read, we encourage you to ask questions, share your thoughts, or send general input/requests to our team at www.pall.com/ continuous-questions.

We hope that this supplement encourages a deeper discussion about continuous bioprocessing technology and the dramatic impact it can have — and already is having — on the biopharmaceutical industry. Beginning with a look back at the history of continuous processing in other industries and moving forward to the potential it has in the bioprocessing industry, we move into how Pall is working to continuously improve bioprocesses. Our special issue closes with projections for the future.

Thank you to everyone who participated in the creation of this supplement, whether directly or indirectly. The editorial team gets special recognition for their time and dedication to producing this supplement.

On behalf of Pall Corporation, please enjoy — and thank you for your time spent reading and sharing the content in these pages.

Martin Smith, PhD
CTO, Pall Corporation